Biblio
Export 239 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is B [Clear All Filters]
“Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
, “Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
, “Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
, “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
, “The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.”, J Alzheimers Dis, vol. 59, no. 3, pp. 893-901, 2017.
, “Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1113-1123, 2018.
, “Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
, “Nutrition: Review on the Possible Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
, “Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
, “Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1343-1353, 2020.
, “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
, “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
, “Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
, “Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1445-1458, 2018.
, “Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
, “The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”, J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
, “Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
, “Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
, “Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.”, J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
, “A Novel Plasma Based Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 3, pp. 761-71, 2015.
, “Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.”, J Alzheimers Dis, vol. 56, no. 2, pp. 775-788, 2017.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1409-1424, 2018.
, “Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.”, J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
,